In August, Apple launched a “redesigned” version of the Apple Watch’s Blood Oxygen feature in the United States. This came 18 months after Apple started selling the Apple Watch without the Blood Oxygen feature in due to a patent dispute with health technology company Masimo.
The International Trade Commission (ITC) now says that it is holding a new proceeding to decide if this solution should also be banned due to the Masimo patent dispute.